MHC Class II Tetramer
reagents to study antigen-specific CD4+ T cell immune responses
Join us in Oxford on March 21, 2016
Mastering Immunity Europe 2016 a
focussed one-day conference to learn the latest developments in the fast-moving area of biological drugs, immunotherapies and vaccines.
Mastering Immunity 5, the latest conference held by ProImmune, was a huge success - the videos from this year's conference are now
Webcast: ProStorm® Cytokine Release Assay: how does it work?
Meet ProImmune at the following events in 2016:
PEPTALK, San Diego, CA, USA, Jan 18-22
GTC 4th Immunogenicity & Immunotoxicity Conference, San Diego, CA, USA, Jan 25-26
EIP 2016, Algarve, Portugal, Feb 22-24
PEGS 2016, Boston, MA, USA, Apr 25-29
Latest customer publications
Pro5® MHC Pentamers used in study
published by scientists at
Genentech to demonstrate that cross
presentation is more efficient that direct presentation of influenza
Figure from: Smed-Sörensen A, Chalouni C, Chatterjee B, Cohn
L, et al. (2012) Influenza A Virus Infection of Human Primary
Dendritic Cells Impairs Their Ability to Cross-Present Antigen to
CD8 T Cells.
PLoS Pathog 8(3): e1002572. doi:10.1371/journal.ppat.1002572